VENUSREM Intraday Analysis...

VENUSREM Share Price

Open 98.85 Change Price %
High 98.85 1 Day -3.10 -3.15
Low 94.70 1 Week -10.10 -9.58
Close 95.30 1 Month -15.75 -14.18
Volume 36204 1 Year 25.65 36.83
52 Week High 142.50
52 Week Low 65.20
VENUSREM Important Levels
Resistance 2 99.15
Resistance 1 97.56
Pivot 96.28
Support 1 93.04
Support 2 91.45
NSE INDIA Most Active Stocks
SUZLON 18.85 -4.56%
JPASSOCIAT 9.30 -9.27%
RCOM 25.90 -7.50%
SINTEX 104.10 -0.48%
GMRINFRA 14.55 -8.49%
SOUTHBANK 25.25 -1.37%
TATAMOTORS 469.55 4.23%
HDIL 83.85 1.08%
IBREALEST 159.80 -3.76%
JINDALSTEL 111.10 2.73%
More..
NSE INDIA Top Gainers Stocks
KSERASERA 0.15 50.00%
VISESHINFO 0.15 50.00%
KESARENT 100.80 20.00%
ELECTHERM 237.75 19.98%
XCHANGING 60.60 12.33%
SPCENET 0.55 10.00%
FMNL 77.85 9.96%
INDOTHAI 33.95 9.87%
MAITHANALL 420.10 9.13%
GENUSPAPER 5.40 9.09%
More..
NSE INDIA Top Losers Stocks
RASOYPR 0.15 -25.00%
AUSTRAL 0.25 -16.67%
ORTEL 75.70 -15.13%
SPYL 0.30 -14.29%
GTOFFSHORE 11.95 -13.09%
SITASHREE 5.15 -12.71%
SATHAISPAT 41.15 -11.51%
NICCO 0.40 -11.11%
MUKANDLTD 66.95 -10.73%
LSIL 1.75 -10.26%
More..

Venus Remedies Limited (NSE: VENUSREM)

VENUSREM Technical Analysis 4
As on 24th May 2017 VENUSREM Share Price closed @ 95.30 and we RECOMMEND Sell for LONG-TERM with Stoploss of 99.61 & Strong Sell for SHORT-TERM with Stoploss of 102.33 we also expect STOCK to react on Following IMPORTANT LEVELS.
VENUSREM Target for May
1st Target up-side 114.85
2nd Target up-side 122.07
3rd Target up-side 129.29
1st Target down-side 94.25
2nd Target down-side 87.03
3rd Target down-side 79.81
VENUSREM Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 33.84 Sideways
MFI (14) MFI is 62.90 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Short Sell 107.54
10 Day Avg Volume Traded -48.10 % Less then 10 Day Average Volume
VENUSREM Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.venusremedies.com
VENUSREM Address
VENUSREM
Plot 51-52, Industrial Area
Phase I
Panchkula, 134113
India
Phone: 91 17 2325 0571
Fax: 91 17 2256 5566
VENUSREM Latest News
Venus Remedies bags patent for antibiotic Vancoplus   Hindu Business Line   - 09th Feb 15
Venus Remedies receives approval for pain reliever drug Trois in Singapore   Business Standard   - 30th Sep 14
Venus Remedies eyes tie-ups for out-licensing drugs   Economic Times   - 23rd Sep 14
Venus Remedies Ltd updates on downgrade by CRISIL   Equity Bulls   - 17th Sep 14
Venus Remedies looking to raise $20M through QIP   VC Circle   - 04th Sep 14
Venus Remedies - Extension of time for holding AGM   Moneycontrol.com   - 01st Sep 14
Venus Remedies Ltd rallies on strategic tie-up with Teva   Economic Times   - 27th Aug 14
Venus Remedies Ltd. : Venus Remedies signs MoU for Elores with South African ...   4-traders (press release)   - 17th Dec 13
Mr. Pawan Chaudhary, Managing Director, Venus Remedies Ltd   India Infoline.com   - 20th May 11
Pawan Chaudhary, MD, Venus Remedies Ltd.   India Infoline.com   - 17th Aug 10
Interactive Technical Analysis Chart Venus Remedies Limited ( VENUSREM NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Venus Remedies Limited
VENUSREM Business Profile
Venus Remedies Limited manufactures and trades medicines in India and internationally. It primarily offers fixed dosage injectable products. The company’s product portfolio includes approximately 75 products in various therapeutic segments comprising oncology, anti infective, neurology, cardiology, orthopedic, pediatrics, and surgery. It offers its products under the Mebatic, Calridol, Moximicin, Neurotol, Glutapep, Doxol, Paxol, Citabol, Epirol, Ronem, Immunox, Pimcef, Fejet IV, Parin-E, Vanconex, Elores, Supime, Tobracef, Vancoplus, Potentox, Pirotum, and other brand names. The company was incorporated in 1989 and is headquartered in Panchkula, India.